Cigna Group $CI Shares Sold by Natixis Advisors LLC

Natixis Advisors LLC trimmed its stake in Cigna Group (NYSE:CI) by 13.5% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 347,023 shares of the health services provider’s stock after selling 54,003 shares during the quarter. Natixis Advisors LLC owned approximately 0.13% of Cigna Group worth $100,029,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Harbor Capital Advisors Inc. increased its holdings in shares of Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after acquiring an additional 49 shares during the period. Collier Financial bought a new stake in Cigna Group in the 3rd quarter valued at about $34,000. Traub Capital Management LLC acquired a new position in Cigna Group during the 2nd quarter valued at about $48,000. Twin Peaks Wealth Advisors LLC bought a new position in Cigna Group in the 2nd quarter worth about $52,000. Finally, CNB Bank grew its position in Cigna Group by 479.4% in the 3rd quarter. CNB Bank now owns 197 shares of the health services provider’s stock worth $57,000 after purchasing an additional 163 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $271.50 on Monday. The stock has a market cap of $71.55 billion, a PE ratio of 12.24, a price-to-earnings-growth ratio of 0.94 and a beta of 0.27. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $280.71 and a 200-day simple moving average of $283.97.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same period in the previous year, the firm earned $6.64 earnings per share. Cigna Group’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is currently 28.13%.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Guggenheim reaffirmed a “buy” rating and set a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. Zacks Research raised Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Jefferies Financial Group raised their target price on Cigna Group from $310.00 to $333.00 and gave the company a “buy” rating in a research report on Monday, February 9th. Mizuho set a $325.00 target price on Cigna Group in a research note on Friday, January 9th. Finally, Leerink Partners increased their price target on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $330.42.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.